Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Impact of UTT on anticipated stigma among patients newly diagnosed with HIV in Johannesburg, South Africa

View through CrossRef
ABSTRACT Background Anticipated stigma – the fear that HIV diagnosis and status disclosure could have negative social implications – may adversely affect engagement with HIV care and treatment, despite universal eligibility for treatment under universal-test-and-treat (UTT). We aimed to determine the prevalence and predictors of anticipated stigma among newly HIV-diagnosed individuals in the context of universal access to treatment in Johannesburg, South Africa. Methods We conducted a cross-sectional survey of 652 newly HIV-diagnosed adults (≥18 years) (64.1% female, with a median age of 33 years and an interquartile range [IQR] of 28–39 years) enrolled from October 2017 to August 2018 at four primary healthcare clinics in Johannesburg. Participants were interviewed immediately after receiving their HIV test results. We used an adapted five-item, four-point scale measuring agreement with statements regarding HIV disclosure concerns and HIV status concealment (Cronbach’s alpha =.82). Mean scores were categorized as “low-to-medium” (score<=2.5), or “high” (score>2.5). We used Modified Poisson regression to assess predictors of high anticipated stigma and report adjusted risk ratios (aRR) with 95% confidence intervals (CIs). Results Overall, 55% of study participants had high anticipated stigma; 55.8% for males, 61.1% for 18–29-year-olds, and 43% for those married. Individuals in an unmarried relationship were more likely to experience high anticipated stigma than those married (aRR 1.10, 95% CI: 1.01-1.18). High anticipated stigma was lower among: older individuals (aRR 0.94 for being 30-39 vs 18-29 years, 95% CI: 0.88-0.99), those with a primary home in another province/rural area (aRR 0.82 another province vs current house, 95% CI: 0.78-0.87) or another country (aRR 0.83 another country vs current house, 95% CI: 0.78-0.88), those living in current homes for ≥5 years (aRR 0.93 for >5 years vs <1 year, 95% CI: 0.88-0.99), those with low ART concerns (aRR 0.86, 95 % CI: 0.82-0.90), and those with low perceived social-support (aRR 0.79 for low vs high, 95 % CI: 0.70-0.88). Conclusion Over 50% of adults diagnosed with HIV in the UTT era had high anticipated stigma. Findings highlight the need to address factors that continue to drive anticipated stigma, to improve social integration and mitigate the potential impact on engagement in HIV care. In addition, enhancing coping skills among individuals living with HIV is crucial.
Title: Impact of UTT on anticipated stigma among patients newly diagnosed with HIV in Johannesburg, South Africa
Description:
ABSTRACT Background Anticipated stigma – the fear that HIV diagnosis and status disclosure could have negative social implications – may adversely affect engagement with HIV care and treatment, despite universal eligibility for treatment under universal-test-and-treat (UTT).
We aimed to determine the prevalence and predictors of anticipated stigma among newly HIV-diagnosed individuals in the context of universal access to treatment in Johannesburg, South Africa.
Methods We conducted a cross-sectional survey of 652 newly HIV-diagnosed adults (≥18 years) (64.
1% female, with a median age of 33 years and an interquartile range [IQR] of 28–39 years) enrolled from October 2017 to August 2018 at four primary healthcare clinics in Johannesburg.
Participants were interviewed immediately after receiving their HIV test results.
We used an adapted five-item, four-point scale measuring agreement with statements regarding HIV disclosure concerns and HIV status concealment (Cronbach’s alpha =.
82).
Mean scores were categorized as “low-to-medium” (score<=2.
5), or “high” (score>2.
5).
We used Modified Poisson regression to assess predictors of high anticipated stigma and report adjusted risk ratios (aRR) with 95% confidence intervals (CIs).
Results Overall, 55% of study participants had high anticipated stigma; 55.
8% for males, 61.
1% for 18–29-year-olds, and 43% for those married.
Individuals in an unmarried relationship were more likely to experience high anticipated stigma than those married (aRR 1.
10, 95% CI: 1.
01-1.
18).
High anticipated stigma was lower among: older individuals (aRR 0.
94 for being 30-39 vs 18-29 years, 95% CI: 0.
88-0.
99), those with a primary home in another province/rural area (aRR 0.
82 another province vs current house, 95% CI: 0.
78-0.
87) or another country (aRR 0.
83 another country vs current house, 95% CI: 0.
78-0.
88), those living in current homes for ≥5 years (aRR 0.
93 for >5 years vs <1 year, 95% CI: 0.
88-0.
99), those with low ART concerns (aRR 0.
86, 95 % CI: 0.
82-0.
90), and those with low perceived social-support (aRR 0.
79 for low vs high, 95 % CI: 0.
70-0.
88).
Conclusion Over 50% of adults diagnosed with HIV in the UTT era had high anticipated stigma.
Findings highlight the need to address factors that continue to drive anticipated stigma, to improve social integration and mitigate the potential impact on engagement in HIV care.
In addition, enhancing coping skills among individuals living with HIV is crucial.

Related Results

HIV WGS - 400bp Amplicon Tiling - Oxford Nanopore Technology Protocol v1
HIV WGS - 400bp Amplicon Tiling - Oxford Nanopore Technology Protocol v1
OSPHL in collaboration with APHL, will evaluate the performance of the Oxford Nanopore Technology sequencers for HIV genome sequencing using a modified protocol of the ARTIC amplic...
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
Abstract Introduction Human immunodeficiency virus (HIV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) surface glycoproteins, including shared epitope motifs, sho...
Capítulo 6 – HIV-AIDS, como tratar, o que fazer e o que não fazer durante o tratamento?
Capítulo 6 – HIV-AIDS, como tratar, o que fazer e o que não fazer durante o tratamento?
A infecção pelo vírus do HIV pode ocorrer de diversas maneiras, tendo sua principal forma a via sexual por meio do sexo desprotegido. O vírus do HIV fica em um período de incubação...
Evaluasi peningkatan pengetahuan tentang HIV/AIDS dan sikap terhadap ODHA di SMK Gelora Jaya Nusantara
Evaluasi peningkatan pengetahuan tentang HIV/AIDS dan sikap terhadap ODHA di SMK Gelora Jaya Nusantara
Background: HIV/AIDS remains a global health problem in Indonesia, with major barriers being misunderstandings, social stigma, and ineffective educational approaches. The level of ...
Double Stigma Among Pregnant Adolescents Living With HIV in Northern Uganda: A Pilot Cross-Sectional Study
Double Stigma Among Pregnant Adolescents Living With HIV in Northern Uganda: A Pilot Cross-Sectional Study
Abstract Background Despite a global decline in HIV/AIDS incidence, adolescent girls and young women in sub-Saharan Africa remain disproportionately affected. Pregnant ado...
Laboratory-based Evaluation of Wondfo HIV1/2 Rapid Test Kits in the Gambia, December 2020
Laboratory-based Evaluation of Wondfo HIV1/2 Rapid Test Kits in the Gambia, December 2020
Background: HIV rapid diagnosis in The Gambia is mainly done using Determine HIV-1/2 and First Response HIV 1.2.0 or SD Bioline HIV-1/2 3.0 for screening and sero-typing of HIV res...
Impact of HIV/AIDS scale-up on non-HIV priority services in Nyanza Province, Kenya
Impact of HIV/AIDS scale-up on non-HIV priority services in Nyanza Province, Kenya
Background: The HIV pandemic has attracted unprecedented scale-up in resources to curb its escalation and manage those afflicted. Although evidence from developing countries sugges...

Back to Top